Skip to main content
Top
Published in: Journal of Neurology 6/2018

01-06-2018 | Original Communication

Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson’s disease

Authors: Tanja Stojkovic, Elka Stefanova, Ivan Soldatovic, Vladana Markovic, Iva Stankovic, Igor Petrovic, Federica Agosta, Sebastiano Galantucci, Massimo Filippi, Vladimir Kostic

Published in: Journal of Neurology | Issue 6/2018

Login to get access

Abstract

Objective

To determine frequency and type of cognitive disorders in cross-sectional analysis of a Parkinson’s disease (PD) cohort, and explore its relations to motor symptoms, modifiable vascular risk factors and white matter lesions (WML) volume.

Methods

In a group of 133 PD patients, mild cognitive impairment (PD-MCI) and dementia (PDD) were diagnosed according to Movement Disorders Society Task Force criteria (level 2 for PD-MCI). Detailed motor measurements were applied, including rigidity, axial, bradykinesia, tremor and postural instability gait disorders (PIGD) scores. Vascular risk was estimated by the Framingham General Cardiovascular Disease risk scoring algorithm and WML volume was measured for whole brain and frontal lobe.

Results

Sixty-one (46.9%) patients fulfilled criteria for PD-MCI, and 23 (17.7%) for PDD. Non-amnestic multiple domain MCI was most frequent (52% of PD-MCI patients). Motor scores were significantly higher in cognitively impaired patients, but only axial score discriminated between MCI and dementia. High vascular risk was related to impaired cognition, bradykinesia, axial, PIGD and freezing of gait (FOG) score, while whole brain WML volume was associated with PDD, FOG and attention deficits. Furthermore, high vascular risk was identified as a potential predictor of both MCI and dementia in PD. Additionally, age and bradykinesia score were independently associated with PD-MCI and age, axial score and whole brain WML volume with PDD.

Conclusion

Cognitive disorders in PD are associated with more severe, predominantly axial motor deficits and increased, but partly modifiable vascular burden, thus opening a possibility for development of preventive strategies in PD.
Literature
1.
go back to reference Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13(4):217–231CrossRefPubMedPubMedCentral Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13(4):217–231CrossRefPubMedPubMedCentral
2.
go back to reference Winter Y, von Campenhausen S, Arend M, Longo K, Boetzel K, Eggert K, Oertel WH, Dodel R, Barone P (2011) Health-related quality of life and its determinants in Parkinson’s disease, results of an Italian cohort study. Parkinsonism Relat Disord 17:265–269CrossRefPubMed Winter Y, von Campenhausen S, Arend M, Longo K, Boetzel K, Eggert K, Oertel WH, Dodel R, Barone P (2011) Health-related quality of life and its determinants in Parkinson’s disease, results of an Italian cohort study. Parkinsonism Relat Disord 17:265–269CrossRefPubMed
3.
go back to reference Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A (2010) Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord 25:1170–1176CrossRefPubMedPubMedCentral Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A (2010) Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord 25:1170–1176CrossRefPubMedPubMedCentral
4.
go back to reference Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK (2009) Clinical features in early Parkinson disease and survival. Arch Neurol 66:1353–1358CrossRefPubMed Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK (2009) Clinical features in early Parkinson disease and survival. Arch Neurol 66:1353–1358CrossRefPubMed
5.
go back to reference Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson’s disease the dual syndrome hypothesis. Neurodegener Dis 11:79–92CrossRefPubMed Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson’s disease the dual syndrome hypothesis. Neurodegener Dis 11:79–92CrossRefPubMed
6.
go back to reference Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, Montine TJ, Zabetian CP, Leverenz JB (2015) Association of cognitive domains with postural instability/gait disturbance in Parkinson’s disease. Parkinsonism Relat Disord 21:692–697CrossRefPubMedPubMedCentral Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, Montine TJ, Zabetian CP, Leverenz JB (2015) Association of cognitive domains with postural instability/gait disturbance in Parkinson’s disease. Parkinsonism Relat Disord 21:692–697CrossRefPubMedPubMedCentral
7.
go back to reference Veselý B, Rektor I (2016) The contribution of white matter lesions (WML) to Parkinson’s disease cognitive impairment symptoms: a critical review of the literature. Parkinsonism Relat Disord 22:66–70CrossRef Veselý B, Rektor I (2016) The contribution of white matter lesions (WML) to Parkinson’s disease cognitive impairment symptoms: a critical review of the literature. Parkinsonism Relat Disord 22:66–70CrossRef
8.
go back to reference Veselý B, Antonini A, Rektor I (2016) The contribution of white matter lesions to Parkinson’s disease motor and gait symptoms: a critical review of the literature. J Neural Transm 123(3):241–250CrossRefPubMed Veselý B, Antonini A, Rektor I (2016) The contribution of white matter lesions to Parkinson’s disease motor and gait symptoms: a critical review of the literature. J Neural Transm 123(3):241–250CrossRefPubMed
9.
go back to reference Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG, PRoBaND Clinical Consortium (2016) Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson’s disease. Mov Disord 31(10):1518–1526CrossRefPubMedPubMedCentral Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG, PRoBaND Clinical Consortium (2016) Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson’s disease. Mov Disord 31(10):1518–1526CrossRefPubMedPubMedCentral
10.
go back to reference Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI (2014) Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology 82:1514–1520CrossRefPubMedPubMedCentral Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI (2014) Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology 82:1514–1520CrossRefPubMedPubMedCentral
11.
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentral
12.
go back to reference Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640CrossRefPubMed Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640CrossRefPubMed
13.
go back to reference Hoehn MM, Yahr MD (1967) Parkinsonism onset, progression and mortality. Neurology 15:427–442CrossRef Hoehn MM, Yahr MD (1967) Parkinsonism onset, progression and mortality. Neurology 15:427–442CrossRef
14.
go back to reference Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003) The Unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 18:738–750CrossRef Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003) The Unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 18:738–750CrossRef
15.
go back to reference Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529–1534CrossRefPubMed Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529–1534CrossRefPubMed
16.
go back to reference Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2000) Motor impairment in PD relationship to incident dementia and age. Neurology 55:539–544CrossRefPubMed Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2000) Motor impairment in PD relationship to incident dementia and age. Neurology 55:539–544CrossRefPubMed
17.
go back to reference Khoo T, Tilley B, Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170CrossRef Khoo T, Tilley B, Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170CrossRef
18.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-mental state’, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-mental state’, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
19.
go back to reference Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R) a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R) a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed
20.
go back to reference Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment (MoCA) a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment (MoCA) a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed
23.
go back to reference Marin RS (1996) Apathy, concept, syndrome, mechanisms and treatment. Neural Clin Neuropsychiatry 1:303–314 Marin RS (1996) Apathy, concept, syndrome, mechanisms and treatment. Neural Clin Neuropsychiatry 1:303–314
24.
go back to reference Lezak M (1983) Neuropsychological assessment, 2nd edn. Oxford University Press, New York Lezak M (1983) Neuropsychological assessment, 2nd edn. Oxford University Press, New York
25.
go back to reference Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5:266–281PubMed Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5:266–281PubMed
26.
go back to reference Stefanova E, Žiropadja L, Stojković T, Stanković I, Tomić A, Ječmenica-Lukić M, Petrović I, Kostić V (2015) Mild cognitive impairment in early Parkinson’s disease using the Movement Disorder Society Task Force criteria: cross-sectional study in Hoehn and Yahr stage 1. Dement Geriatr Cogn Disord 40:199–209CrossRefPubMed Stefanova E, Žiropadja L, Stojković T, Stanković I, Tomić A, Ječmenica-Lukić M, Petrović I, Kostić V (2015) Mild cognitive impairment in early Parkinson’s disease using the Movement Disorder Society Task Force criteria: cross-sectional study in Hoehn and Yahr stage 1. Dement Geriatr Cogn Disord 40:199–209CrossRefPubMed
27.
go back to reference Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease. Mov Disord Soc Task Force Guidel Mov Disord 27:349–356CrossRef Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease. Mov Disord Soc Task Force Guidel Mov Disord 27:349–356CrossRef
28.
go back to reference Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRefPubMed Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRefPubMed
29.
go back to reference Biundo R, Weis L, Antonini A (2016) Cognitive decline in Parkinson’s disease the complex picture, npj. Parkinson’s Dis 2:1–7 Biundo R, Weis L, Antonini A (2016) Cognitive decline in Parkinson’s disease the complex picture, npj. Parkinson’s Dis 2:1–7
30.
go back to reference Braak H, Rüb U, Steur EJ, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64(8):1404–1411CrossRefPubMed Braak H, Rüb U, Steur EJ, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64(8):1404–1411CrossRefPubMed
31.
go back to reference Yarnall AJ, Rochester L, Burn DJ (2013) Mild cognitive impairment in Parkinson’s disease. Age Aging 42:567–576CrossRef Yarnall AJ, Rochester L, Burn DJ (2013) Mild cognitive impairment in Parkinson’s disease. Age Aging 42:567–576CrossRef
32.
go back to reference Wills AM, Li R, Pérez A, Ren X, Boyd J, Investigators NINDSNET-PD (2017) Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort. J Neurol 264(8):1746–1753CrossRefPubMedPubMedCentral Wills AM, Li R, Pérez A, Ren X, Boyd J, Investigators NINDSNET-PD (2017) Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort. J Neurol 264(8):1746–1753CrossRefPubMedPubMedCentral
33.
go back to reference Lee PC, Ahmed I, Loriot MA, Mulot C, Paul KC, Bronstein JM, Ritz B, Elbaz A (2018) Smoking and Parkinson disease: evidence for gene-by-smoking interactions. Neurology 90(7):e583–e592CrossRefPubMedPubMedCentral Lee PC, Ahmed I, Loriot MA, Mulot C, Paul KC, Bronstein JM, Ritz B, Elbaz A (2018) Smoking and Parkinson disease: evidence for gene-by-smoking interactions. Neurology 90(7):e583–e592CrossRefPubMedPubMedCentral
34.
go back to reference Román GC, Boller F (2014) Vascular factors in neurodegenerative diseases a path towards treatment and prevention. Funct Neurol 29:85–86PubMedPubMedCentral Román GC, Boller F (2014) Vascular factors in neurodegenerative diseases a path towards treatment and prevention. Funct Neurol 29:85–86PubMedPubMedCentral
35.
go back to reference Sławek J, Wieczorek D, Derejko M, Dubaniewicz M, Brockhuis B, Sitek E, Wilczewska L, Roszmann A, Lass P (2010) Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson’s disease. Parkinsonism Relat Disord 16(1):73–74 (author reply 75–6) CrossRefPubMed Sławek J, Wieczorek D, Derejko M, Dubaniewicz M, Brockhuis B, Sitek E, Wilczewska L, Roszmann A, Lass P (2010) Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson’s disease. Parkinsonism Relat Disord 16(1):73–74 (author reply 75–6) CrossRefPubMed
36.
go back to reference Moore SF, Barker RA (2014) Predictors of Parkinson’s disease dementia towards targeted therapies for a heterogeneous disease. Parkinsonism Relat Disord 20(Suppl 1):S104–S107CrossRefPubMed Moore SF, Barker RA (2014) Predictors of Parkinson’s disease dementia towards targeted therapies for a heterogeneous disease. Parkinsonism Relat Disord 20(Suppl 1):S104–S107CrossRefPubMed
37.
go back to reference Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R et al (2013) The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement 9:657–665CrossRefPubMed Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R et al (2013) The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement 9:657–665CrossRefPubMed
Metadata
Title
Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson’s disease
Authors
Tanja Stojkovic
Elka Stefanova
Ivan Soldatovic
Vladana Markovic
Iva Stankovic
Igor Petrovic
Federica Agosta
Sebastiano Galantucci
Massimo Filippi
Vladimir Kostic
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8838-3

Other articles of this Issue 6/2018

Journal of Neurology 6/2018 Go to the issue